Hot Pursuit     03-Jun-23
Zydus Life gets zero observation from USFDA for Ahmedabad facility
Zydus Lifesciences said that it has received nil observations for inspection conducted by US Food and Drug Administration (USFDA) at group's animal health drug manufacturing facility at SEZ, Ahmedabad.
The inspection by the USFDA was conducted from 30 May 2023 to 2 June 2023.

Zydus Lifesciences is a discovery-driven, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company's consolidated net profit (from continuing operations) tumbled 27.55% to Rs 298.8 crore despite of 31.66% jump in total revenue from operations to Rs 5,010.6 crore in Q4 FY23 over Q4 FY22.

The scrip rose 1.01% to end at Rs 518.55 on Friday, 2 June 2023.

Previous News
  Zydus Lifesciences Ltd leads losers in 'A' group
 ( Hot Pursuit - 16-Apr-25   15:00 )
  Zydus' transdermal patch manufacturing facility completes USFDA inspection
 ( Corporate News - 01-Oct-24   12:26 )
  Zydus Life launches ANVIMO for HSCT and Kidney transplant treatment
 ( Hot Pursuit - 05-Mar-25   10:20 )
  Zydus Life gets final approval from USFDA for Paliperidone drug
 ( Hot Pursuit - 10-Oct-24   14:51 )
  Zydus Animal Health and Investment to divest its stake held in Mylan
 ( Corporate News - 16-Dec-24   12:50 )
  Zydus Lifesciences Q3 PAT jumps 30% YoY to Rs 1,023 cr
 ( Hot Pursuit - 05-Feb-25   15:20 )
  Zydus Life’s Zynext Ventures invests in Illexcor Theraputics for SCD therapies
 ( Hot Pursuit - 13-Mar-25   11:16 )
  Zydus Lifesciences appoints senior management personnel
 ( Corporate News - 03-Jan-25   12:56 )
  Zydus Life Jarod facility receives USFDA warning letter
 ( Hot Pursuit - 30-Aug-24   15:11 )
  Zydus Life’s Ahmedabad facility gets EIR from USFDA
 ( Hot Pursuit - 01-Oct-24   12:13 )
  Zydus Life jumps on USFDA nod for BP lowering drug
 ( Hot Pursuit - 04-Jul-24   16:28 )
Other Stories
  HDFC Bank Q4 PAT rises 7% YoY to Rs 17,616 cr; NII rises 10%
  19-Apr-25   18:04
  Yes Bank Q4 PAT climbs 63% YoY to Rs 738 cr
  19-Apr-25   16:20
  Mastek Q4 PAT slides 14% QoQ to Rs 81 cr; recommends final dividend of Rs 16/sh
  19-Apr-25   14:31
  Tata Elxsi posts PAT of Rs 172 crore in Q4; EBITDA margin at 20.5%
  19-Apr-25   12:47
  Mahindra EPC records more than fourfold rise in Q4 PAT
  19-Apr-25   11:04
  Just Dial Q4 PAT climbs 36% YoY to Rs 158 cr
  19-Apr-25   10:02
  Jio Financial Services Q4 PAT rises 2% YoY to Rs 316 cr
  19-Apr-25   08:57
  HDFC Life Q4 PAT climbs 16% YoY to Rs 476 cr
  17-Apr-25   17:32
  Infosys Q4 PAT rises 3% QoQ to Rs 7,038 cr; declares dividend of Rs 22/sh
  17-Apr-25   17:25
  HDFC AMC rises after Q4 PAT jumps 18% YoY to Rs 639 cr; declares final dividend of Rs 90/sh
  17-Apr-25   17:11
Back Top